Technology - Human 3D mini organs
Bonds Bio Innovation
Unlock Physiological Relevance with 3D BioSol™
At Bonds Bio, our dedicated team manufacture scaffold-free adipose tissue, heart, liver, and vascular spheroids and organoids in-house. Designed to offer unparalleled accuracy in exploring metabolic disorders and cellular cardiotoxicity, our models leverage cutting-edge technologies and processes.
Seamlessly integrating into your drug discovery and development workflows, our proprietary, user-friendly formats empower you to concentrate on your core objectives.
Relevance
- The 3D BioSol™ Process meticulously crafts mini organs, replicating in-vivo-like morphology and functionality.
- Our organoids excel in capturing the enduring impact of drugs, offering unparalleled longevity for in-depth analysis.
Elevating Quality Assurance
Achieve Lot-to-Lot Consistency with Pre-Qualified Donor Materials
- Our commitment to excellence includes the use of pre-qualified donor materials, ensuring consistent quality across multiple lots.
- Certify the Functional Validity of Your Models through 3D Applications, Mitigating the Risk of Failures.
Maximizing Efficiency
On-Demand Mini Organs with Unparalleled Experimental Flexibility
- Experience the freedom of on-demand mini organs without compromising experimental flexibility.
- Effortlessly Access Ready-to-Use Assay Solutions, Complete with 3D Organoids, Optimized Media, and Certified Protocols.
Process
Revolutionizing Science Through Innovative Processes
Readouts
Revolutionizing Science Through Precise Metrics
Applications
Revolutionize Drug Discovery: Elevate Efficacy and Safety
Embark on a transformative journey in drug discovery – magnify efficacy and ensure safety with the groundbreaking power of 3D BioSol™
Copyright © 2024 Bonds Biosystems Corporation - All Rights Reserved.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.